Tear fluid test for glioblastoma detection
Part of Cancer clinical trials.
This study looks at tear fluid to find tiny particles released by glioblastoma tumors, which could offer a new way to monitor the disease. Participation involves a simple, non-invasive tear collection with a small paper strip.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with glioblastoma (a type of brain cancer) or be a healthy volunteer.
- If you have glioblastoma, you need to have a Rickham reservoir or shunt (a small device implanted for treatment) already in place.
- You must be willing to have your tears collected using a small strip of paper placed in your eye.
- You cannot have active eye infections, inflammation, recent eye surgery, chronic dry eyes, or be allergic to numbing eye drops.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special MRI scans and a contrast agent to look at the immune environment of glioblastoma tumors. It may help doctors learn more about how the tumor responds to treatment.
This study looks at proteins in the fluid around the brain and spine of people with glioblastoma to learn more about the tumor and find better ways to diagnose and treat it. You would give samples of fluid, blood, and tumor tissue, and have follow-up care at a specific hospital.
This study aims to improve understanding of glioblastoma (and gliosarcoma) by preserving live, usable brain-tissue samples during brain surgery. If you’re having repeat tumor surgery or your scans suggest these cancers, the study may ask to collect tissue for research.
This study looks at how the brain's protective barrier works in people with glioblastoma. Researchers will study tumor tissue and use special scans to learn more, which might help improve future treatments.
This trial tests whether testing drugs on your tumor cells in a lab can help find the best treatment for you. It is for people with a specific type of glioblastoma that has not been treated yet.
This study tests a device that samples fluid from the brain during surgery to better understand brain tumors and epilepsy. It may help researchers learn more about these conditions without extra risk to you.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.